Table 3.
Basic characteristics of the study population for the pregnant group and non-pregnant group
Pregnant group | Non-pregnant group | P | |
---|---|---|---|
Female, age (year) | 28.32±3.32 | 28.76±3.48 | NS |
Female, BMI | 23.66±3.79 | 23.48±3.97 | NS |
Male, age (year) | 29.65±3.72 | 30.05±4.00 | NS |
Male, BMI | 26.35±16.28 | 26.85±18.29 | NS |
Infertility years | 2.51±1.43 | 2.67±2.45 | NS |
Baseline hormones | |||
FSH (IU/L) | 7.11±1.92 | 7.19±1.99 | NS |
LH (IU/L) | 7.97±9.97 | 7.33±8.29 | NS |
PRL (mIU/L) | 311.20±173.90 | 302.01±155.42 | NS |
E2 (pmol/L) | 173.60±195.53 | 175.15±81.91 | NS |
T (pmol/L) | 1.66±0.70 | 1.64±0.71 | NS |
P (nmol/L) | 2.08±1.45 | 2.24±2.54 | NS |
AMH (ng/mL) | 6.00±3.69 | 5.22±3.46** | 0.001519 |
Subjects in AMH categories by age | |||
20-30 | 6.32±3.71 | 5.62±3.61* | 0.017 |
31-34 | 5.20±3.67 | 4.36±2.90 | NS |
≥35 | 3.84±1.83 | 3.77±2.57 | NS |
*P<0.05, **P<0.01. NS=Non-significant, BMI=Body mass index, FSH=Follicle-stimulating hormone, LH=Luteinising hormone, PRL=Prolactin, E2=Oestradiol, AMH=Anti-Mullerian hormone, T=Testosterone, P=Progesterone